INDIANAPOLIS, Indiana (May 28, 2025) – – Despite recent gyrations in the U.S. economy, VisionTech and its network of 120-plus angel investors continue to back entrepreneurs whose technology has the potential to disrupt and transform entire market categories. In the first four months of 2025 alone, VisionTech has invested $1,003,600 million in eight deals, with participation from 65 investors.

Three of VisionTech’s early 2025 deals are new investments made in companies with deep Indiana connections:

HAPPE Spine is commercializing the INTEGRATE-C interbody fusion cage that supports faster bone growth thanks to proprietary materials and manufacturing processes. Founder, CEO, and inventor Ryan Roeder earned his undergraduate, graduate and PhD degrees from Purdue University; completed a fellowship at the Indiana University School of Medicine; and is now a Notre Dame University research professor. HAPPE’s platform technology can be applied to a range of other implanted medical devices. VisionTech investors wrote checks totaling $274,850 to HAPPE.

Oro Muscles is revolutionizing rehabilitation with AI-powered real-time, actionable insights into muscle activity with live biofeedback and instant analysis. Already, more than 50 percent of Major League Baseball teams, Major League Soccer, and other elite professional and collegiate teams are using Oro Muscles’ technology. The company was co-founded by Rose Hulman Institute alumni Tanya Colonna and Hobey Tam. VisionTech investors chipped in $191,250 to Oro Muscles.

SinuSauna has developed a respiratory wellness product that employs dry heat rather than messy liquids to keep nasal passages clear. Two of SinuSauna’s co-founders, Drs. Jack Townsend and Matthew Zielenski, are graduates of the Indiana University School of Medicine. The company was launched out of Indianapolis’ Boomerang Ventures. VisionTech investors contributed $146,500 to SinuSauna.

VisionTech’s five remaining investments were follow-on rounds in current VisionTech portfolio companies totaling $391,000. They include:

Augment Therapy
NuvOx Therapeutics
Akadeum Life Sciences
Safekeeping/How’s Mom
Stamus Networks

VisionTech Executive Director Ben Pidgeon says he’s not surprised by the level of his group’s investments so early in 2025. “Our deal flow continues to offer high potential opportunities to invest in promising early growth companies. Our investors have a passion for startups and appreciate being involved in early-stage companies that are on the cutting edge of innovation. They are not just writing checks; they interact with the founders and CEOs, drive our due diligence process, provide mentoring, and participate on our portfolio companies’ boards. Our investors enjoy making an impact with our portfolio companies.”

Angel investing is a class investing where accredited individual investors and groups provide capital to startup companies, typically in early stages of commercialization, in exchange for convertible debt or ownership equity. The VisionTech model of angel investing provides structure and autonomy.

“We have proven processes for screening, due diligence and portfolio management; the best practices of the Angel Capital Association; and national and state connections critical for quality deal flow. Along with that, each member drives their own destiny. They decide what deals to invest in and how much as well as how involved they want to be with our portfolio companies,” Pidgeon says.

“Our members have their fingers on the pulse of some of the hottest, most innovative technology around. It’s fun!” he adds.

VisionTech is not resting on this early success. Two exciting companies in the life sciences and pharmaceutical space pitch the group in May, with another pitch set for June 2 with another disruptive pharmaceutical investment opportunity.

About VisionTech
Founded in 2009, VisionTech is a privately held company that links investors to high-potential, early-growth companies. Based in Indianapolis, VisionTech’s angel investing network includes more than 120 active members across Indiana and Ohio. As of April 30, 2025, the group has deployed more than $32.6 million in capital, investing in 72 portfolio companies from Indiana and across the United States. VisionTech is a member of the Angel Capital Association. Membership is open to accredited investors. Those interested in joining are encouraged to contact VisionTech. For media relations, contact Melanie Lux.